Monomeric form of C-reactive protein in the assessment of the residual inflammatory cardiovascular risk in patients with subclinical carotid atherosclerosis
Autor: | I. S. Melnikov, S. G. Kozlov, O. A. Pogorelova, M. I. Tripoten, O. S. Saburova, L. Sh. Khamchieva, Yu. N. Avtaeva, M. D. Zvereva, L. V. Prokofieva, T. V. Kuznetsova, O. A. Guseva, T. V. Balakhonova, Z. A. Gabbasov |
---|---|
Rok vydání: | 2022 |
Předmět: | |
Zdroj: | Kardiologiia. 62:24-30 |
ISSN: | 2412-5660 0022-9040 |
DOI: | 10.18087/cardio.2022.7.n2137 |
Popis: | Aim To study the relationship between monomeric C-reactive protein (mCRP) and the progression of asymptomatic carotid atherosclerosis in patients with a moderate risk for cardiovascular diseases (CVD) as assessed with the SCORE model.Material and methods The study included 80 men and women aged 53.1±5.8 years assigned to the category of a moderate risk for CVDs by the SCORE model with a low-density lipoprotein cholesterol (LDL-C) level of 2.7–4.8 mmol/l and asymptomatic, hemodynamically insignificant (Results A concentration of LDL-C Conclusion According to the results of 7-year follow-up, the plasma concentration of mCRP was significantly higher in patients with an increased number of ASPs than in patients without this increase. An increased level of mCRP may indicate a higher inflammatory risk of CVD. |
Databáze: | OpenAIRE |
Externí odkaz: |